Gujarat Terce Laboratories Ltd Quarterly Results
Q2 FY21-22 Results Summary
Revenue
The revenue stands at ₹10.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.91 per cent from ₹9.94 crore. This corresponds to a year-on-year *(YoY) growth of 8.46 per cent.
Operating Profit
Operating Profit stands at ₹0.54 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 66.87 per cent from ₹1.63 crore. This corresponds to a year-on-year *(YoY) growth of 208.00 per cent.
PBDT
PBDT stands at ₹0.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 69.70 per cent from ₹1.65 crore. This corresponds to a year-on-year *(YoY) growth of 247.06 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 71.88 per cent from ₹1.60 crore. This corresponds to a year-on-year *(YoY) growth of 209.76 per cent.
Net Profit
Net Profit stands at ₹0.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 71.88 per cent from ₹1.60 crore. This represents a 178.95 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Gujarat Terce Laboratories Ltd Earnings
- YOY
- QOQ
Gujarat Terce Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gujarat Terce Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Gujarat Terce Laboratories Ltd Financial Reports
Gujarat Terce Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Guj. Terce Labs. | -0.64% | -11.56% | 7.54% | 6.00% | -10.19% | -11.83% |
| Roopa Industries | -1.55% | -4.87% | -8.86% | -12.27% | -2.17% | -19.00% |
| Chandra Bhagat | 4.98% | 15.71% | 30.52% | 44.88% | 19.23% | -18.97% |
| Medico Intercon. | 3.39% | 5.83% | 10.79% | 40.42% | -17.12% | -14.64% |
| Deep Health AI | -1.00% | -0.50% | -3.40% | -11.56% | -47.35% | -48.18% |
| Remedium Life | -3.13% | -6.06% | -3.13% | -22.50% | -65.56% | -76.69% |
| Venmax Drugs | 4.36% | 3.52% | -7.95% | -25.83% | -35.76% | -37.02% |
Company Info
Company Information
Whole-time Director : Amrutbhai P Prajapati
Independent Director : Chhayaben Ashwinbhai Shah
Independent Director : Viplav Suryakantbhai Khamar
Managing Director & Chief Executive Officer : Aalap Prajapati
Independent Director : Surendra Kumar Sharma
Chairman & Wholetime Director : Natwarbhai P Prajapati
Independent Director : Avani Vishnubhai Patel
Company Sec. & Compli. Officer : Ripalben Sachinkumar Sukhadiya